Sir Andrew Witty to co-lead WHO COVID-19 vaccine effort
Sir Andrew will take leave from his current role until the end of the year
Read More
Tag: Sir Andrew Witty
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
